Published in J Cancer Res Clin Oncol on October 02, 2007
Indoleamine 2,3-dioxygenase: is it an immune suppressor? Cancer J (2010) 1.36
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy. Oncoimmunology (2013) 1.29
Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy. Immunotherapy (2009) 1.10
The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer. J Transl Med (2009) 1.08
Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunol Invest (2012) 1.05
Regulation of tumor immunity by tumor/dendritic cell fusions. Clin Dev Immunol (2010) 0.94
Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer. Oncoimmunology (2013) 0.94
Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes. BMC Cancer (2009) 0.83
PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. J Immunol Res (2015) 0.79
Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines. J Biomed Biotechnol (2011) 0.77
UPDATE ON VACCINE DEVELOPMENT FOR RENAL CELL CANCER. Open Access J Urol (2010) 0.77
Update on vaccine development for renal cell cancer. Open Access J Urol (2010) 0.76
Dendritic-Tumor Fusion Cell-Based Cancer Vaccines. Int J Mol Sci (2016) 0.76
Therapeutic cancer vaccines and combination immunotherapies involving vaccination. Immunotargets Ther (2014) 0.75
The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy. Onco Targets Ther (2017) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
Cancer immunotherapy: moving beyond current vaccines. Nat Med (2004) 17.61
Prevention of allogeneic fetal rejection by tryptophan catabolism. Science (1998) 9.80
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med (2003) 7.86
Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol (2003) 5.47
Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J (1991) 5.30
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med (2005) 4.92
Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol (2000) 3.46
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. J Clin Invest (2005) 3.11
4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat Med (2004) 3.01
Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J Immunol (2005) 2.51
Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood (1999) 2.47
Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol (2001) 2.23
Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells. Immunity (2002) 2.18
Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol (2002) 2.14
Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int J Cancer (2002) 2.10
IDO and tolerance to tumors. Trends Mol Med (2004) 2.03
Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest (2004) 1.98
Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology (2003) 1.91
Immune suppression in the tumor microenvironment. J Immunother (2006) 1.90
Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation. Curr Opin Immunol (2006) 1.65
Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase. J Biol Chem (1986) 1.58
Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol (2000) 1.47
The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol Today (1997) 1.34
T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. Cancer Res (2001) 1.22
Dendritic cells pulsed with HER-2/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer. Clin Cancer Res (2002) 1.18
Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. J Immunol (1998) 1.17
Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO. J Immunol (2006) 1.09
Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine. J Immunol (2003) 1.06
Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors. Expert Opin Ther Targets (2005) 1.02
Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene. J Immunol (2006) 0.98
Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression. Cancer Immunol Immunother (2006) 0.97
Dendritic cells presenting tumor antigen. Cancer Immunol Immunother (1996) 0.95
Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells. Mol Ther (2003) 0.95
Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentiviruses. J Immunol (2004) 0.91
Binding activity of H-Ras is necessary for in vivo inhibition of ASK1 activity. Cell Res (2004) 0.88
Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12. Cancer Gene Ther (2005) 0.86
T cell proliferation is blocked by indoleamine 2,3-dioxygenase. Transplant Proc (2001) 0.84
The therapeutic potential of 4-1BB (CD137) in cancer. Curr Cancer Drug Targets (2005) 0.84
Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells. Cell Immunol (1999) 0.81
Nasopharyngeal carcinoma and the EBV-specific T cell response: prospects for immunotherapy. Semin Cancer Biol (2002) 0.80
Therapeutic efficacy of MUC1-specific cytotoxic T lymphocytes and CD137 co-stimulation in a spontaneous breast cancer model. Breast Dis (2004) 0.79
Cell fusion: an approach to generating constitutively proliferating human tumor antigen-presenting cells. Cancer Immunol Immunother (2002) 0.78
Dendritic cell/myeloma hybrid vaccine. Methods Mol Med (2005) 0.76
Induction of autologous CD4- and CD8-mediated T-cell responses against acute lymphocytic leukemia cell line using apoptotic tumor cell-loaded dendritic cells. Exp Hematol (2006) 0.75
Halted trial renews questions about cancer vaccines. Nat Med (2004) 0.75
Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science (2011) 13.16
The role of DNA shape in protein-DNA recognition. Nature (2009) 5.52
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem (2005) 5.33
The developmental dynamics of the maize leaf transcriptome. Nat Genet (2010) 4.02
Cofactor binding evokes latent differences in DNA binding specificity between Hox proteins. Cell (2011) 3.40
Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell (2013) 3.13
Severe fever with thrombocytopenia syndrome virus, Shandong Province, China. Emerg Infect Dis (2012) 2.77
Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol (2002) 2.58
A comparison of statistical methods for detecting differentially expressed genes from RNA-seq data. Am J Bot (2012) 2.44
Designing a wearable navigation system for image-guided cancer resection surgery. Ann Biomed Eng (2014) 2.33
A brassinosteroid transcriptional network revealed by genome-wide identification of BESI target genes in Arabidopsis thaliana. Plant J (2011) 2.19
Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat Genet (2005) 2.10
The Relationship Between Helicobacter pylori Infection and Open-Angle Glaucoma: A Meta-Analysis. Invest Ophthalmol Vis Sci (2015) 1.94
Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry (2005) 1.76
Scaling up prevention programmes to reduce the sexual transmission of HIV in China. Int J Epidemiol (2010) 1.71
miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull (2009) 1.66
A low-cost library construction protocol and data analysis pipeline for Illumina-based strand-specific multiplex RNA-seq. PLoS One (2011) 1.60
Fluoride and children's intelligence: a meta-analysis. Biol Trace Elem Res (2008) 1.57
Microstructure abnormalities in adolescents with internet addiction disorder. PLoS One (2011) 1.56
Inhibiting expression of specific genes in mammalian cells with 5' end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA. Proc Natl Acad Sci U S A (2003) 1.55
Obligate heterodimerization of Arabidopsis phytochromes C and E and interaction with the PIF3 basic helix-loop-helix transcription factor. Plant Cell (2009) 1.52
A new tumor vaccine: FAPτ-MT elicits effective antitumor response by targeting indolamine2,3-dioxygenase in antigen presenting cells. Cancer Biol Ther (2011) 1.49
Resistance to obesity by repression of VEGF gene expression through induction of brown-like adipocyte differentiation. Endocrinology (2012) 1.47
miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. Carcinogenesis (2012) 1.45
Primary non-Hodgkin lymphomas in the small and large intestine: clinicopathological characteristics and management of 40 patients. Int J Hematol (2008) 1.45
Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population. Leuk Lymphoma (2011) 1.44
Characterization of 582 natural and synthetic terminators and quantification of their design constraints. Nat Methods (2013) 1.42
Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling. Autophagy (2011) 1.40
Necroptosis: an emerging form of programmed cell death. Crit Rev Oncol Hematol (2011) 1.38
Computational explorations of mechanisms and ligand-directed selectivities of copper-catalyzed Ullmann-type reactions. J Am Chem Soc (2010) 1.36
Plasma soluble corin in patients with heart failure. Circ Heart Fail (2010) 1.36
Geographic distance and pH drive bacterial distribution in alkaline lake sediments across Tibetan Plateau. Environ Microbiol (2012) 1.36
A map of minor groove shape and electrostatic potential from hydroxyl radical cleavage patterns of DNA. ACS Chem Biol (2011) 1.35
Effects of gas supersaturation on lethality and avoidance responses in juvenile rock carp (Procypris rabaudi Tchang). J Zhejiang Univ Sci B (2010) 1.34
Enhanced 2,3-butanediol production by Klebsiella oxytoca using a two-stage agitation speed control strategy. Bioresour Technol (2009) 1.33
Receptor-like kinase OsSIK1 improves drought and salt stress tolerance in rice (Oryza sativa) plants. Plant J (2010) 1.32
Clinical features of solitary necrotic nodule of the liver. Hepatobiliary Pancreat Dis Int (2008) 1.32
Nuance in the double-helix and its role in protein-DNA recognition. Curr Opin Struct Biol (2009) 1.32
The WD40 domain is required for LRRK2 neurotoxicity. PLoS One (2009) 1.32
Epithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer. PLoS One (2013) 1.31
Stress-induced alternative splicing provides a mechanism for the regulation of microRNA processing in Arabidopsis thaliana. Mol Cell (2012) 1.31
A multi-treatment experimental system to examine photosynthetic differentiation in the maize leaf. BMC Genomics (2007) 1.29
Polycomb protein Cbx4 promotes SUMO modification of de novo DNA methyltransferase Dnmt3a. Biochem J (2007) 1.29
Engineering Klebsiella oxytoca for efficient 2, 3-butanediol production through insertional inactivation of acetaldehyde dehydrogenase gene. Appl Microbiol Biotechnol (2009) 1.27
Suzuki-Miyaura cross-coupling of aryl carbamates and sulfamates: experimental and computational studies. J Am Chem Soc (2011) 1.26
Growth rate, catalase and superoxide dismutase activities in rock carp (Procypris rabaudi Tchang) exposed to supersaturated total dissolved gas. J Zhejiang Univ Sci B (2011) 1.24
Time-varied characteristics of acupuncture effects in fMRI studies. Hum Brain Mapp (2009) 1.23
The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clin Immunol (2007) 1.22
A first generation microsatellite- and SNP-based linkage map of Jatropha. PLoS One (2011) 1.19
Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma. Ann Hematol (2011) 1.19
Catalytic ketyl-olefin cyclizations enabled by proton-coupled electron transfer. J Am Chem Soc (2013) 1.19
PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration. Cell Signal (2012) 1.19
Crystal structure of human vacuolar protein sorting protein 29 reveals a phosphodiesterase/nuclease-like fold and two protein-protein interaction sites. J Biol Chem (2005) 1.17
Biotransformation and metabolic profile of American ginseng saponins with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry. J Chromatogr A (2013) 1.15
IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy. Biomaterials (2013) 1.14
Transcriptome-wide changes in Chlamydomonas reinhardtii gene expression regulated by carbon dioxide and the CO2-concentrating mechanism regulator CIA5/CCM1. Plant Cell (2012) 1.14
Effects of controlled-release fertiliser on nitrogen use efficiency in summer maize. PLoS One (2013) 1.13
A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells. Biochemistry (2010) 1.12
N'-(3,5-Dichloro-2-hydroxy-benzyl-idene)-3-methoxy-benzohydrazide methanol solvate. Acta Crystallogr Sect E Struct Rep Online (2008) 1.12
Origins of differences in reactivities of alkenes, alkynes, and allenes in [Rh(CO)2Cl]2-catalyzed (5 + 2) cycloaddition reactions with vinylcyclopropanes. J Am Chem Soc (2008) 1.12
Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors. Am J Surg Pathol (2010) 1.10
Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells. Cancer Res (2010) 1.10
Mechanism and transition-state structures for nickel-catalyzed reductive alkyne-aldehyde coupling reactions. J Am Chem Soc (2009) 1.09
HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells. Cancer Res (2011) 1.09
Decomposition pathways of Z-selective ruthenium metathesis catalysts. J Am Chem Soc (2012) 1.09
c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor. Mol Cell (2013) 1.08
Phytoremediation of urban wastewater by model wetlands with ornamental hydrophytes. J Environ Sci (China) (2007) 1.08
Donor-acceptor conjugated polymer based on naphtho[1,2-c:5,6-c]bis[1,2,5]thiadiazole for high-performance polymer solar cells. J Am Chem Soc (2011) 1.08
Biocompatible graphene oxide nanoparticle-based drug delivery platform for tumor microenvironment-responsive triggered release of doxorubicin. Langmuir (2014) 1.08
Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study. Chemotherapy (2007) 1.07
Model-based clustering for RNA-seq data. Bioinformatics (2013) 1.07
Mapping QTLs for oil traits and eQTLs for oleosin genes in jatropha. BMC Plant Biol (2011) 1.07
Clinical features of hepatic angiomyolipoma. Hepatobiliary Pancreat Dis Int (2008) 1.07
Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. Lung Cancer (2007) 1.07
Origin of enantioselectivity in CF3-PIP-catalyzed kinetic resolution of secondary benzylic alcohols. J Am Chem Soc (2008) 1.07
Leaf rolling controlled by the homeodomain leucine zipper class IV gene Roc5 in rice. Plant Physiol (2011) 1.07
Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states. Pain (2011) 1.06
A membrane microdomain-associated protein, Arabidopsis Flot1, is involved in a clathrin-independent endocytic pathway and is required for seedling development. Plant Cell (2012) 1.06
Long-term disability from acute childhood Japanese encephalitis in Shanghai, China. Am J Trop Med Hyg (2007) 1.06
Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host. Antimicrob Agents Chemother (2011) 1.05
Estradiol increases hematopoietic stem and progenitor cells independent of its actions on bone. Haematologica (2012) 1.05
Structure and function of glucose-6-phosphate dehydrogenase-deficient variants in Chinese population. Hum Genet (2006) 1.04
Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression. Biochim Biophys Acta (2012) 1.04
Regional homogeneity abnormalities in patients with interictal migraine without aura: a resting-state study. NMR Biomed (2011) 1.03
AC3-33, a novel secretory protein, inhibits Elk1 transcriptional activity via ERK pathway. Mol Biol Rep (2010) 1.03
An anti-let-7 sponge decoys and decays endogenous let-7 functions. Cell Cycle (2012) 1.03
Kinetic resolution of 2-hydroxybutanoate racemic mixtures by NAD-independent L-lactate dehydrogenase. Bioresour Technol (2011) 1.03
A qualitative study on commercial sex behaviors among male clients in Sichuan Province, China. AIDS Care (2010) 1.03
Nitric oxide modulates the influx of extracellular Ca2+ and actin filament organization during cell wall construction in Pinus bungeana pollen tubes. New Phytol (2009) 1.03
New threats to health data privacy. BMC Bioinformatics (2011) 1.03
Proteomic analysis of rat pheochromocytoma PC12 cells. Proteomics (2006) 1.03
Mechanism and enantioselectivity in palladium-catalyzed conjugate addition of arylboronic acids to β-substituted cyclic enones: insights from computation and experiment. J Am Chem Soc (2013) 1.02
A modified "cross-talk" between histone H2B Lys-120 ubiquitination and H3 Lys-79 methylation. J Biol Chem (2010) 1.02
Mesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug delivery. Angew Chem Int Ed Engl (2010) 1.02
Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination. Vaccine (2010) 1.02
miR-138 protects cardiomyocytes from hypoxia-induced apoptosis via MLK3/JNK/c-jun pathway. Biochem Biophys Res Commun (2013) 1.01
3D resolved mapping of optical aberrations in thick tissues. Biomed Opt Express (2012) 1.01
Multiple endoplasmic reticulum-to-nucleus signaling pathways coordinate phospholipid metabolism with gene expression by distinct mechanisms. J Biol Chem (2006) 1.01
A large-scale, high-efficiency and low-cost platform for structural genomics studies. Acta Crystallogr D Biol Crystallogr (2006) 1.01